Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China flag China · Delayed Price · Currency is CNY
1.380
-0.030 (-2.13%)
Aug 31, 2026, 3:00 PM CST

Kangmei Pharmaceutical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,9655,2525,1894,8744,1804,153
Revenue Growth
-6.18%1.22%6.46%16.60%0.66%-23.27%
Gross Profit
950.88948.5653.37728.86431.1491.52
Operating Income
-245.61-221.55-413.53179.59-1,040-3,046
Net Income
29.4610.338.57102.52-2,6887,918
Earnings Per Share
0.000.000.000.01-0.190.57
EPS Growth
266.46%16.67%-94.00%---

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Traditional Chinese Medicine, Western Medicine and Medical Devices
4,2194,2413,8763,4343,407
Health Food and Food
500.27437.48502.79324.58184.23
Property Leasing and Sales and Others
532.62510.55494.89421.95560.99
Total
5,2525,1894,8744,1804,153

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,3451,240977.921,0571,5082,419
Total Debt
168.86184.36139.13255.01263.87205.29
Net Cash (Debt)
1,1771,056838.8801.681,2442,214
Net Cash Growth
52.58%25.87%4.63%-35.54%-43.82%-
Net Cash Per Share
0.100.070.060.080.090.16

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
229.52111.35-427.63-317.52-749.96214.21
Capital Expenditures
-217.71-217.06-61.71-99.74-48.12-171.63
Free Cash Flow
11.8-105.71-489.34-417.27-798.0842.58
Free Cash Flow Growth
------94.16%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
19.15%18.06%12.59%14.95%10.31%2.20%
Operating Margin
-4.95%-4.22%-7.97%3.69%-24.89%-73.37%
Pretax Margin
1.12%0.82%0.67%2.26%-63.73%196.39%
Profit Margin
0.59%0.20%0.17%2.10%-64.31%190.68%
FCF Margin
0.24%-2.01%-9.43%-8.56%-19.09%1.03%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
661.842557.443783.85251.53-5.41
Forward PE
-2.562.562.562.562.56
P/FCF Ratio
1651.92----1006.12
PS Ratio
3.935.036.255.297.3010.32